Therapy Analysis & Statistics, April 2014 (p20)

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

571-600 of about 4 800 reports

Purchase Reports From Reputable Market Research Publishers

Vital Therapies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vital Therapies, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Vital Therapies, Inc. (Vital Therapies) is a healthcare company. The company provides treatment of liver failure with the development of ELAD. Its product is ELAD, which is a human-cell-based bioartificial ...

  • Industries : Therapy
  • Countries : United States
Mercury Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mercury Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Mercury Pharmaceuticals, Inc. (Mercury) is a pharmaceutical company. The company discovers and develops orally active small molecule activators of AMP-activated protein kinase (AMPK). It AMPK serves ...

  • Industries : Therapy
  • Countries : United States
Onconova Therapeutics, Inc. (ONTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Onconova Therapeutics, Inc. (ONTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Onconova Therapeutics, Inc (Onconova) is a biopharmaceutical company based in the US. The company develops products for cancer and also protects healthy cells. It develops targeted anti-cance ...

  • Industries : Therapy
  • Countries : United States
Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Opexa Therapeutics, Inc. (OPXA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Opexa Therapeutics, Inc. (Opexa) is a biotechnology company. The company develops autologous cellular therapies for the treatment of sclerosis, rheumatoid arthritis, diabetes and heart failure. ...

  • Industries : Therapy
  • Countries : United States
Galena Biopharma, Inc. (GALE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Galena Biopharma, Inc. (GALE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Galena Biopharma, Inc. (Galena) is a biotechnology company. The company discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its products ...

  • Industries : Therapy
  • Countries : United States
Repros Therapeutics Inc. (RPRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Repros Therapeutics Inc. (RPRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Repros Therapeutics Inc. (Repros) is a biopharmaceutical company. The company develops oral small molecule drugs for major unmet medical needs in male and female health. Its product pipeline includes ...

  • Industries : Therapy
  • Countries : United States
Celsus Therapeutics Plc (CLTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celsus Therapeutics Plc (CLTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Celsus Therapeutics Plc (Celsus) is a drug development company. The company develops anti-inflammatory and multi-functional anti-inflammatory drugs. Its product pipeline includes MRX6- topical ...

  • Industries : Therapy
  • Countries : United States
Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nanobiotix SA (NANO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Nanobiotix is a nanomedicine company. It focuses on developing an innovative nanoparticle technology. The company is formulating innovative tools that act physically at the cellular level in cance ...

  • Industries : Therapy
Galectin Therapeutics, Inc. (GALT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Galectin Therapeutics, Inc. (GALT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include ...

  • Industries : Therapy
  • Countries : Georgia
JAK and PI3K Signaling Pathway Markets

JAK and PI3K Signaling Pathway Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion ...

  • Industries : Therapy
  • Countries : World
Pain Therapeutics, Inc., Wright Investors' Service

Pain Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Pain Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Therapy
  • Countries : China
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Hormone Refractory ...

  • Industries : Therapy
  • Countries : World
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Therapy
  • Countries : World, United States
Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • April 2014
  • by Global Data

Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Therapy
  • Countries : World
InterMune, Inc. (Symbol:ITMN) SWOT Analysis, Strategy, Revenues and Profits

InterMune, Inc. (Symbol:ITMN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Europe, Canada
Chelsea Therapeutics International Ltd. (Symbol:CHTP) SWOT Analysis, Strategy, Revenues and Profits

Chelsea Therapeutics International Ltd. (Symbol:CHTP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Corcept Therapeutics Incorporated (Symbol:CORT) SWOT Analysis, Strategy, Revenues and Profits

Corcept Therapeutics Incorporated (Symbol:CORT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Oxygen Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Oxygen Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • April 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • April 2014
  • by GBI Research

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading ...

  • Industries : Therapy
  • Countries : World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth

HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth

  • $ 3 500
  • Industry report
  • April 2014
  • by GBI Research

HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth Summary The leading business ...

  • Industries : Therapy
  • Countries : World
Negative Pressure Wound Therapy Powered Suction Pumps - Medical Device Safety and Approval Report - Comprehensive

Negative Pressure Wound Therapy Powered Suction Pumps - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Negative Pressure Wound Therapy Powered Suction Pumps, recent device approvals, supplements, recalls, and ...

  • Industries : Therapy
Cardiac Resynchronization Therapy Defibrillators (CRT-D) - Medical Device Safety and Approval Report - Comprehensive

Cardiac Resynchronization Therapy Defibrillators (CRT-D) - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Cardiac Resynchronization Therapy Defibrillators (CRT-D), recent device approvals, supplements, recalls, ...

  • Industries : Therapy
Diagnostics and Therapeutics for HIV: Global Markets

Diagnostics and Therapeutics for HIV: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for products used in the treatment, testing ...

  • Industries : Therapy
  • Countries : World
Global Glaucoma Therapeutics Market  2014-2018

Global Glaucoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • April 2014
  • by Infiniti Research Limited

About Glaucoma Therapeutics Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of ...

  • Industries : Therapy
  • Countries : World
Beta Radiation Therapy Systems - Medical Device Safety and Approval Report - Comprehensive

Beta Radiation Therapy Systems - Medical Device Safety and Approval Report - Comprehensive

  • $ 299
  • Industry report
  • April 2014
  • by DeviceMatters

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Beta Radiation Therapy Systems, recent device approvals, supplements, recalls, and in-depth review of adverse ...

  • Industries : Therapy
Osiris Therapeutics, Inc. (Symbol:OSIR) SWOT Analysis, Strategy, Revenues and Profits

Osiris Therapeutics, Inc. (Symbol:OSIR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2014
  • by Global Data

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
  • Countries : Spain
Dendreon Corporation (Symbol:DNDN) SWOT Analysis, Strategy, Revenues and Profits

Dendreon Corporation (Symbol:DNDN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
DARA BioSciences, Inc. (Symbol:DARA) SWOT Analysis, Strategy, Revenues and Profits

DARA BioSciences, Inc. (Symbol:DARA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : United States
Oxford BioTherapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxford BioTherapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biotechnology company. It focuses on the development antibody drug conjugates (ACDs) for the treatment of wide variety of cancers. The ...

  • Industries : Therapy
  • Countries : United States
About 700 reports

Download Unlimited Documents from Trusted Public Sources

General Medicine And Specialty Medicine Industry - Company Report, July 2014

  • Prostate Cancer Treatment: Unproven Proton Radiation Therapy Was...
  • July 2014
    4 pages
  • Radiation Thera...  

    Prostate Cancer  

  • United States  

View report >

About 100 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.